血管グラフトの中国市場2021-2028:製品別、用途別(腎不全、血管閉塞、冠状動脈疾患)、原材料別

調査会社Grand View Research社が発行したリサーチレポート(データ管理コード:GV21OT060)
◆英語タイトル:China Vascular Grafts Market Size, Share & Trends Analysis Report By Product, By Application (Kidney Failure, Vascular Occlusion, Coronary Artery Disease), By Raw Material, And Segment Forecasts, 2021 - 2028
◆発行会社/調査会社:Grand View Research
◆商品コード:GV21OT060
◆発行日:2021年10月5日
◆調査対象地域:中国
◆産業分野:医療機器
◆ページ数:120
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール(3営業日)
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥678,300見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥792,300見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥1,020,300見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
Grand View Research社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[血管グラフトの中国市場2021-2028:製品別、用途別(腎不全、血管閉塞、冠状動脈疾患)、原材料別]についてメールでお問い合わせはこちら
グランドビューリサーチ社は、血管グラフトの中国市場規模が2028年までに172.8百万ドルに達すると予測しています。2021年から2028年までの間に年平均8.6%成長する見通しです。本調査資料は、中国の血管グラフト市場について調査し、調査手法・範囲、エグゼクティブサマリー、市場変動・動向・範囲、競争分析、製品別分析、用途別分析、原材料別分析、地域別分析、企業情報などの項目を掲載しています。
*** レポート概要(サマリー)***

China Vascular Grafts Market Growth & Trends
The China vascular grafts market size is expected to reach USD 172.8 million by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 8.6% from 2021 to 2028. The increasing prevalence of cardiovascular diseases, diabetes, and end-stage renal disease are the factors driving the market. The rise in the number of people suffering from these conditions is expected to boost the demand for these products in the coming years. In addition, the development of novel technologies, such as tissue-engineered materials, is expected to boost overall revenue over the forecast period. The COVD-19 pandemic has negatively impacted the country’s growth due to the increasing focus on COVID-19 treatment and recommended deferrals of elective medical procedures in the country.

In 2020, the endovascular stent-grafts product segment held the largest revenue share. The growth in the adoption of minimally invasive endovascular procedures due to their benefits such as short hospital stays low mortality rate, and perioperative morbidity, driving the segment growth. On the other hand, the peripheral vascular grafts segment is anticipated to be the fastest-growing segment during the forecast period owing to the increasing number of patients suffering from peripheral artery disease in China.

The cardiac aneurysm application segment accounted for the largest revenue share in 2020. The increasing prevalence of unruptured saccular aneurysms, affecting the flow of intracranial arteries, is expected to boost the adoption of these products over the forecast period. Abdominal Aortic Aneurysms (AAA) have a worse prognosis in men and have gained considerable attention in recent years, hence, gender-specific research about the development of novel products is expected to gain momentum over the forecast period. On the other hand, vascular occlusion application is expected to be the fastest-growing segment during the forecast period due to the increasing prevalence of vascular occlusive diseases and the easy availability of graft procedures. Technological advancements resulting in the development of novel therapies, which help to reduce the severity of acute ischemia after occlusion of PTFE grafts and thereby, minimizing the risks associated with prosthetic vascular grafts.

As of 2020, the polytetrafluoroethylene raw material segment accounted for the largest revenue share. It is anticipated to witness the fastest CAGR during the forecast period. Multiple applications of polytetrafluoroethylene vascular grafts, such as replacement of diseased arteries and creation of dialysis access site, along with many players offering a variety of polytetrafluoroethylene-based products are among factors supporting overall growth. In addition, easy availability of raw material and high tensile strength and durability are also responsible for high adoption in China.

China Vascular Grafts Market Report Highlights

• The market is expected to witness significant growth by 2028, owing to rising demand for minimally invasive procedures and the continuous introduction of innovative solutions

• The endovascular stent-grafts segment has dominated the market in 2020 due to increasing consumer preference for minimally invasive endovascular stent-grafts in China

• The cardiac aneurysm application segment dominated the market in 2020 due to the increasing prevalence of cardiovascular diseases in China

• The polytetrafluoroethylene raw material segment dominated the market in 2020 due to the rise in the number of players offering polytetrafluoroethylene vascular grafts

*** レポート目次(コンテンツ)***

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.2 Research Methodology
1.2.1 Information Procurement
1.3 Information or Data Analysis
1.4 Research Scope and Assumptions
1.4.1 Methodology
1.4.1.1 Analysis Of The Company Market Share
1.4.1.2 Analysis Of Commodity Flow Model
1.5 Market Formulation & Validation
1.5.1 China Market: CAGR Calculation
1.5.2 China Segment Share Calculation
1.6 List to Data Sources
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
Chapter 3 China Vascular Grafts Market Variables, Trends & Scope
3.1 Penetration and Growth Prospect Mapping
3.2 China Vascular Grafts Market Dynamics
3.2.1 Market Driver Analysis
3.2.2 Market Restraint Analysis
3.3 China Vascular Grafts Industry Analysis – Porter’s
3.3.1 Bargaining Power Of The Suppliers – Moderate
3.3.2 Bargaining Power Of The Buyers – Moderate
3.3.3 Threat Of Substitution – Low
3.3.4 Threats From New Entrants – Moderate
3.3.5 Competitive Rivalry – High
3.4 China Vascular Grafts Industry Analysis – PEST
3.4.1 Political Landscape
3.4.2 Economic Landscape
3.4.3 Social Landscape
3.4.4 Technology Landscape
3.5 Major Deals & Strategic Alliances Analysis
3.6 Impact of COVID-19 Pandemic on China Vascular Grafts Market
Chapter 4 China Vascular Grafts Market: Competitive Analysis
4.1 Recent Developments & Impact Analysis, By Key Market Participants
4.1.1 Partnerships And Collaborations
4.1.1.1 Cook Medical And Bentley
4.1.1.2 Lombard Medical And Microport Scientific Corporation
4.1.2 Mergers And Acquistions
4.1.2.1 Lemaitre Vascular, Inc. And Artegraft, Inc.
4.1.2.2 Tva Medical, Inc. Acquired By Bd
4.1.2.3 Microport Scientific And Lombard Medical
4.1.2.4 Bd And C. R. Bard, Inc.
4.1.3 Product Approvals
4.1.3.1 China National Medical Products Administration (NMPA) Approved Minos Abdominal Aortic Stent Graft And Delivery System
4.1.3.2 Biotyx Medical’s Ibs Angel Approved By NMPA
4.1.3.3 Artery Stent Graft System Approval By NMPA
4.1.3.4 Lifetech Scientific Corporation Obtained Registration Approval From NMPA
4.1.3.5 Microport Endovascular (Shanghai) Co., Ltd. Announced Regulatory Approval Of Castor By China CFDA
4.2 Company/Competition Categorization (Key Innovators, Market Leaders, Emerging Players)
4.3 Vendor Landscape
4.3.1 List Of Key Distributors/Channel Partners
4.3.2 Key Customers
4.3.3 Company Sales Value, 2016 To 2020, Usd Million
4.3.4 Key Customers List Of Key Emerging Companies/Technology Disruptors/ Innovators
4.3.5 Company Market Position Analysis (Geographical Presence, Product Portfolio, Key Alliance, Industry Experience)
Chapter 5 China Vascular Grafts Market: Product Market Estimates & Trend Analysis
5.1 China Vascular Grafts Market: Product Analysis
5.1.1 Hemodialysis Access Grafts
5.1.1.1 China hemodialysis access grafts market value estimates and forecasts, 2016 – 2028 (USD Million)
5.1.2 Endovascular Stent Grafts
5.1.2.1 China endovascular stent grafts market value estimates and forecasts, 2016 – 2028 (USD Million)
5.1.3 Coronary Artery By-Pass Grafts
5.1.3.1 China coronary artery by-pass grafts market value estimates and forecasts, 2016 – 2028 (USD Million)
5.1.4 Vascular Grafts For Aorta Disease
5.1.4.1 China vascular grafts for aorta disease market value estimates and forecasts, 2016 – 2028 (USD Million)
5.1.5 Peripheral Vascular Grafts
5.1.5.1 China peripheral vascular grafts market value estimates and forecasts, 2016 – 2028 (USD Million)
Chapter 6 China Vascular Grafts Market: Application Estimates & Trend Analysis
6.1 China Vascular Grafts Market: Application Movement Analysis
6.1.1 Cardiac Aneurysm
6.1.1.1 China cardiac aneurysm market estimates and forecasts, 2016 – 2028 (usd mUSD Million)
6.1.1.2 Endovascular Stent Graft
6.1.1.2.1 China endovascular stent graft market estimates and forecasts, 2016 – 2028 (USD Million)
6.1.1.3 Vascular Graft In Cardiac Aneurysm
6.1.1.3.1 China vascular graft in cardiac aneurysm market estimates and forecasts, 2016 – 2028 (USD Million)
6.1.2 Kidney Failure
6.1.2.1 China kidney failure market estimates and forecasts, 2016 – 2028 (USD Million)
6.1.3 Vascular Occlusion
6.1.3.1 China vascular occlusion market estimates and forecasts, 2016 – 2028 (USD Million)
6.1.4 Coronary Artery Disease
6.1.4.1 China coronary artery disease market estimates and forecasts, 2016 – 2028 (USD Million)
Chapter 7 China Vascular Grafts Market: Raw Material Estimates & Trend Analysis
7.1 China Vascular Grafts Market: Raw Material Movement Analysis
7.1.1 Polyester Vascular Grafts
7.1.1.1 China polyester vascular grafts market estimates and forecasts, 2016 – 2028 (USD Million)
7.1.2 Polytetrafluoroethylene Vascular Grafts
7.1.2.1 China polytetrafluoroethylene vascular grafts market estimates and forecasts, 2016 – 2028 (USD Million)
7.1.3 Polyurethane Vascular Grafts
7.1.3.1 china polyurethane vascular grafts market estimates and forecasts, 2016 – 2028 (USD Million)
7.1.4 Biological Material Based Vascular Grafts
7.1.4.1 China biological material based vascular grafts market estimates and forecasts, 2016 – 2028 (USD Million)
7.1.4.2 Human Saphenous and Umbilical Veins
7.1.4.2.1 China human saphenous and umbilical veins market estimates and forecasts, 2016 – 2028 (USD Million)
7.1.4.3 Tissue Engineered Materials
7.1.4.3.1 China tissue engineered materials market estimates and forecasts, 2016 – 2028 (USD Million)
Chapter 8 Competitive Landscape
8.1 Company Profiles
8.1.1 Medtronic plc
8.1.1.1 Company Overview
8.1.1.2 Financial Performance
8.1.1.3 Product Benchmarking
8.1.1.4 Strategic initiatives
8.1.2 Terumo Corporation
8.1.2.1 Company Overview
8.1.2.2 Financial Performance
8.1.2.3 Product Benchmarking
8.1.2.4 Strategic Initiatives
8.1.3 LeMaitre Vascular, Inc.
8.1.3.1 Company Overview
8.1.3.2 Financial Performance
8.1.3.3 Product Benchmarking
8.1.3.4 Strategic Initiatives
8.1.4 C.R. Bard; W.L. Gore and Associates, Inc.
8.1.4.1 Company Overview
8.1.4.2 Financial Performance
8.1.4.3 Product Benchmarking
8.1.4.4 Strategic Initiatives
8.1.5 Cook
8.1.5.1 Company Overview
8.1.5.2 Financial Performance
8.1.5.3 Product Benchmarking
8.1.5.4 Strategic Initiaves
8.1.6 Shanghai Suokang Medical Implants Co. Ltd.
8.1.6.1 Company Overview
8.1.6.2 Financial Performance
8.1.6.3 Product Benchmarking
8.1.6.4 Strategic Initiaves
8.1.7 Getinge AB
8.1.7.1 Company Overview
8.1.7.2 Financial Performance
8.1.7.3 Product Benchmarking
8.1.7.4 Strategic Initiatives

List of Tables

TABLE 1 Company market share analysis, 2020
TABLE 2 Commodity flow model, 2019
TABLE 3 Company sales value, 2016 to 2020, USD Million
TABLE 4 China vascular grafts market, by product, 2016 - 2028 (USD Million)
TABLE 5 China vascular grafts market, by application, 2016 - 2028 (USD Million)
TABLE 6 China Vascular Grafts market for cardiac aneurysm, by application, 2016 - 2028 (USD Million)
TABLE 7 China vascular grafts market, by raw material, 2016 - 2028 (USD Million)
TABLE 8 China vascular grafts market for biological material based vascular grafts, by application, 2016 - 2028 (USD Million)


List of Figures

FIG. 1 China Vascular Grafts market segmentation
FIG. 2 Market research process
FIG. 3 Information procurement
FIG. 4 Primary research pattern
FIG. 5 Market research approaches
FIG. 6 Supply chain-based sizing & forecasting
FIG. 7 QFD modeling for market share assessment
FIG. 8 Company market share analysis, 2016 - 2020
FIG. 9 Commodity flow model
FIG. 10 Market formulation & validation
FIG. 11 Market summary, 2020 (USD Million)
FIG. 12 Market variables and trends analysis
FIG. 13 China vascular grafts market segmentation
FIG. 14 Penetration & growth prospect mapping
FIG. 15 Market driver relevance analysis (Current & future impact)
FIG. 16 Market restraint relevance analysis (Current & future impact)
FIG. 17 Company market position analysis, 2020
FIG. 18 China vascular grafts market, product outlook: Key takeaways (USD Million)
FIG. 19 China vascular grafts market: Product movement analysis (USD Million)
FIG. 20 China hemodialysis access grafts market value estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 21 China endovascular stent grafts market value estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 22 China coronary artery by-pass grafts market value estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 23 China vascular grafts for aorta disease market value estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 24 China peripheral vascular grafts market value estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 25 China vascular grafts market, application outlook: Key takeaways (USD Million)
FIG. 26 China vascular grafts market: application movement analysis (USD Million)
FIG. 27 China cardiac aneurysm market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 28 China endovascular stent graft market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 29 China vascular graft in cardiac aneurysm market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 30 China kidney failure market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 31 China vascular occlusion market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 32 China coronary artery disease market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 33 China vascular grafts market, raw material outlook: Key takeaways (USD Million)
FIG. 34 China vascular grafts market: raw material movement analysis (USD Million)
FIG. 35 China polyester vascular grafts market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 36 China polytetrafluoroethylene vascular market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 37 China polyurethane vascular grafts market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 38 China biological material based vascular grafts market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 39 China human saphenous and umbilical veins market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 40 China tissue engineered materials market estimates and forecasts, 2016 - 2028 (USD Million)

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(GV21OT060 )"血管グラフトの中国市場2021-2028:製品別、用途別(腎不全、血管閉塞、冠状動脈疾患)、原材料別" (英文:China Vascular Grafts Market Size, Share & Trends Analysis Report By Product, By Application (Kidney Failure, Vascular Occlusion, Coronary Artery Disease), By Raw Material, And Segment Forecasts, 2021 - 2028)はGrand View Research社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。